Search by Drug Name or NDC

    NDC 68047-0186-16 NoHist DM 4; 15; 10 mg/5mL; mg/5mL; mg/5mL Details

    NoHist DM 4; 15; 10 mg/5mL; mg/5mL; mg/5mL

    NoHist DM is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Larken Laboratories, Inc.. The primary component is CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 68047-0186
    Product ID 68047-186_078c6cae-4383-bb8d-e063-6294a90a42f9
    Associated GPIs 43995803120930
    GCN Sequence Number 051896
    GCN Sequence Number Description chlorpheniramine/phenyleph/DM LIQUID 4-10-15/5 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 19347
    HICL Sequence Number 000375
    HICL Sequence Number Description CHLORPHENIRAMINE MALEATE/PHENYLEPHRINE HCL/DEXTROMETHORPHAN
    Brand/Generic Generic
    Proprietary Name NoHist DM
    Proprietary Name Suffix n/a
    Non-Proprietary Name Chlorpheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 4; 15; 10
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Larken Laboratories, Inc.
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Rece
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 68047-0186-16 (68047018616)

    NDC Package Code 68047-186-16
    Billing NDC 68047018616
    Package 473 mL in 1 BOTTLE (68047-186-16)
    Marketing Start Date 2011-01-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.06194
    Pricing Unit ML
    Effective Date 2024-01-17
    NDC Description NOHIST-DM LIQUID
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis